Kucuk, A.Uslu, A. U.Ugan, Y.Bagcaci, S.Karahan, A. Y.Akannut, A.Sahin, A.2024-02-232024-02-2320150006-92481336-0345https://doi.org/10.4149/BLL_2015_142https://hdl.handle.net/20.500.12452/16316OBJECTIVE: Ankylosing spondylitis (AS) is a progressive chronic inflammatory disease mainly characterized by axial skeleton and sacroiliac joint involvement. We aimed to investigate the relation between neutrophil-to-lymphocyte ratio (NLR) and disease severity of AS and to explore its availability in clinical practice. METHODS: A total of 102 AS patients and 60 individuals who were age- and gender-compatible with the control group were included into the study. Patients were divided into 2 groups according to Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) scores. Patients with BASDAI scores <4 were considered to be having mild disease activity, whereas those with scores 4 were considered to be displaying severe disease activity. Hemogram test during the diagnosis, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) and other laboratory values of the control group were recorded. RESULTS: NLR was observed to be higher in AS patients compared to the controls (2.47 +/- 1.33 and 1.72 +/- 0.47; respectively; p<0.0001). NLR was observed to be significantly higher in severe AS disease activity compared to the mild AS disease activity (2.72 +/- 1.41, 2.20 +/- 1.19; respectively; p = 0.001). NLR had statistical significant differences between mild disease activity compared to the controls (2.20 +/- 1.19 and 1.72 +/- 0.47, respectively; p = 0.263). There was a positive correlation between NLR and BASDAI (r = 0.193, p = 0.041). The performance of NLR evaluating the disease severity by Roc analysis had sensitivity of 69%, specificity of 54% (cut-off value 1.91), and AUC of 0.652 (95% Cl, 0.549-0.755) (p = 0.006). CONCLUSIONS: NLR may be a simple and inexpensive marker to indicate disease activity in patients with AS in daily clinical practice (Tab. 3, Fig. 3, Ref. 25). Text in PDF www.elis.sk.eninfo:eu-repo/semantics/openAccessAnkylosing SpondylitisBasdaiDiseaseNeutrophil-To-Lymphocyte RatioSeverityArticle11612722725269241412-s2.0-84973279094Q3WOS:000367280800006Q410.4149/BLL_2015_142